V. R. Gopal

P2X Receptor-Stimulated Calcium Responses in Preglomerular Vascular Smooth Muscle Cells Involves 20-Hydroxyeicosatetraenoic Acid

E. Inscho, J. Falck, J. Imig, 2004, Journal of Pharmacology and Experimental Therapeutics.

20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells*

J. Falck, W. Campbell, A. A. Spector, 2004, Journal of Biological Chemistry.

Vascular CO Counterbalances the Sensitizing Influence of 20-HETE on Agonist-Induced Vasoconstriction

J. Falck, Yuan Wei, Wen‐Hui Wang, 2004, Hypertension.

Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding

J. Falck, W. Campbell, Xiu-Yu Yi, 2007, Journal of Pharmacology and Experimental Therapeutics.

Decreased Levels of Cytochrome P450 2E1–Derived Eicosanoids Sensitize Renal Arteries to Constrictor Agonists in Spontaneously Hypertensive Rats

J. Falck, A. Nasjletti, M. Laniado-Schwartzman, 2005, Hypertension.

Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli.

J. Falck, A. Nasjletti, M. Laniado-Schwartzman, 2004, American journal of physiology. Heart and circulatory physiology.

A practical, stereospecific route to 18-, 19-, and 20-hydroxyeicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acids (18-, 19-, and 20-HETEs)

J. Falck, J. Capdevila, V. R. Gopal, 2004 .

20-hydroxyeicosatetraenoic acid (20-HETE): structural determinants for renal vasoconstriction.

J. Falck, R. Roman, J. Falck, 2003, Bioorganic & medicinal chemistry.

Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries.

J. Falck, A. Nasjletti, M. Laniado-Schwartzman, 2003, American journal of physiology. Renal physiology.

Convenient syntheses of [20,20,20-H(3)]-arachidonic acid and [20,20-H(2)]-20-hydroxyeicosatetraenoic acid.

J. Falck, J. Capdevila, V. R. Tuniki, 2006, Journal of labelled compounds & radiopharmaceuticals.